Reports
Sale
Global Recombinant Cell Culture Supplements Market Size, Share, Price, Analysis, Forecast: By Product Type: Recombinant Albumin (rAlbumin), Recombinant Insulin (rInsulin), Recombinant Epidermal Growth Factor (rEGF), Others; By Application; By Expression System; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Recombinant Cell Culture Supplements Market Outlook
The global recombinant cell culture supplements market size was valued at USD 526.98 billion in 2023, driven by the increasing demand for cell-based therapies across the globe. The market size is anticipated to grow at a CAGR of 7.7% during the forecast period of 2024-2032 to achieve a value of USD 1,027.38 billion by 2032.
Recombinant Cell Culture Supplements: Introduction
Recombinant cell culture supplements, which are derived from DNA technology and offer improved performance, consistency, and reproduction, compared to traditional animal derived supplements, have revolutionized cell culture techniques. These products are crucial for the development and growth of cells in the laboratory because they help host cells produce desired proteins or growth factors. The use of recombinant cell culture supplements promotes the growth of healthy and high-performing cells, leading to improved practices and outcomes of desired proteins, antibodies, vaccines, and other biologics. These supplements also enable the optimization of culture conditions, allowing researchers and biomanufacturers to achieve higher cell densities, enhanced protein expression, and more efficient bioprocesses.
Global Recombinant Cell Culture Supplements Market Analysis
There are several key trends running in the market and some of them include the increasing demand for the supplement products without serum and other animal components suggesting industries to make a shift towards this change.
Other factors aiding the recombinant cell culture supplements market growth include the customization and optimization of cell culture supplements, which are based on specific types, and rising focus on regulatory services and quality control in the production and use of recombinant cell culture supplement. The introduction of recombinant cell culture supplements has also revolutionized the field of cell culture by offering consistent and high-quality formulations that can be tailored to meet the specific requirements of different cell lines and applications. These supplements are widely used in biopharmaceutical manufacturing, academic research, and industrial biotechnology.
Global Recombinant Cell Culture Supplements Market Segmentations
Market Breakup by Product Type
- Recombinant Albumin (rAlbumin)
- Recombinant Insulin (rInsulin)
- Recombinant Epidermal Growth Factor (rEGF)
- Recombinant Interleukin Growth Factor (rILGF)
- Recombinant Transferrin (rTransferrin)
- Recombinant Trypsin (rTrypsin)
- Recombinant Insulin-like Growth Factor (rIGF)
- Recombinant Stem Cell Factor (rSCF)
- Recombinant Aprotinin (rAprotinin)
- Recombinant Lysozyme (rLysozyme)
- Others
- Recombinant Transforming Growth Factor (rTGF)
- Recombinant Insulin-Transferrin-Selenium-Ethanolamine (rITSE)
- Recombinant Platelet-Derived Growth Factor (rPDGF)
- Recombinant Leukemia Inhibitory Factor (rLIF)
- Others
Market Breakup by Application
- Regenerative Medicine
- Stem Cell Therapies
- Cell Therapies
- Gene Therapies.
- Bio-Production
- Monoclonal Antibodies
- Recombinant Proteins
- Hormones
- Vaccines
- Other Biological Products
Market Breakup by Expression System
- Mammalian Expression System
- E. coli Expression System
- Yeast Expression System
- Others
Market Breakup by End User
- Academic and Research Institutions
- Biotechnology and Pharmaceutical Companies
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Recombinant Cell Culture Supplements Market Overview
Due to the rising demand for cell-based therapies, along with advancement in production of biopharmaceuticals, the global market for recombinant cell culture supplements is recording a significant growth. The market is expected to witness robust growth in the coming years as well. Other factors aiding the recombinant cell culture supplements market development include the rising awareness about personalised therapies and increasing attention over precision medicine. Due to the demand for more standardised cell culture conditions and cell supplements without serum or any other animal components, the market is making a shift.
Additionally, the increasing demand for animal-free and defined cell culture systems is driving the market growth in both research and biomanufacturing sector. Recombinant cell culture supplements provide a solution by replacing animal-derived components with recombinant counterparts, reducing the risk of contamination, and ensuring regulatory compliance.
Recombinant Cell Culture Supplements Market: Competitor Landscape
The key features of the market report include market landscape, patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abcam plc.
- Corning Incorporated
- BBI Solutions OEM Limited
- FUJIFILM Irvine Scientific, Inc.
- Gemini Bioproducts, LLC
- HiMedia Laboratories, LLC
- Kingfisher Biotech, Inc.
- Lonza Group AG
- Merck KGaA
- Novus Biologicals, LLC
- Thermo Fisher Scientific Inc.
- InVitria
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Expression System |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Recombinant Cell Culture Supplements Market Overview
3.1 Global Recombinant Cell Culture Supplements Market Historical Value (2017-2023)
3.2 Global Recombinant Cell Culture Supplements Market Forecast Value (2024-2032)
4 Global Recombinant Cell Culture Supplements Market Landscape
4.1 Global Recombinant Cell Culture Supplements Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Recombinant Cell Culture Supplements Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Application
4.2.3 Analysis by Expression System
5 Global Recombinant Cell Culture Supplements Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Recombinant Cell Culture Supplements Market Segmentation
6.1 Global Recombinant Cell Culture Supplements Market by Product Type
6.1.1 Market Overview
6.1.2 Recombinant Albumin (rAlbumin)
6.1.3 Recombinant Insulin (rInsulin)
6.1.4 Recombinant Epidermal Growth Factor (rEGF)
6.1.5 Recombinant Interleukin Growth Factor (rILGF)
6.1.6 Recombinant Transferrin (rTransferrin)
6.1.7 Recombinant Trypsin (rTrypsin)
6.1.8 Recombinant Insulin-like Growth Factor (rIGF)
6.1.9 Recombinant Stem Cell Factor (rSCF)
6.1.10 Recombinant Aprotinin (rAprotinin)
6.1.11 Recombinant Lysozyme (rLysozyme)
6.1.12 Others
6.1.12.1 Recombinant Transforming Growth Factor (rTGF)
6.1.12.2 Recombinant Insulin-Transferrin-Selenium-Ethanolamine (rITSE)
6.1.12.3 Recombinant Platelet-Derived Growth Factor (rPDGF)
6.1.12.4 Recombinant Leukemia Inhibitory Factor (rLIF)
6.1.12.5 Others
6.2 Global Recombinant Cell Culture Supplements Market by Application
6.2.1 Market Overview
6.2.2 Regenerative Medicine
6.2.2.1 Stem Cell Therapies
6.2.2.2 Cell Therapies
6.2.2.3 Gene Therapies
6.2.3 Bio-Production
6.2.3.1 Monoclonal Antibodies
6.2.3.2 Recombinant Proteins
6.2.3.3 Hormones
6.2.3.4 Vaccines
6.2.3.5 Other Biological Products
6.3 Global Recombinant Cell Culture Supplements Market by Expression System
6.3.1 Market Overview
6.3.2 Mammalian Expression System
6.3.3 E. coli Expression System
6.3.4 Yeast Expression System
6.3.5 Others
6.4 Global Recombinant Cell Culture Supplements Market by End User
6.4.1 Market Overview
6.4.2 Academic and Research Institutions
6.4.3 Biotechnology and Pharmaceutical Companies
6.4.4 Others
6.5 Global Recombinant Cell Culture Supplements Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Recombinant Cell Culture Supplements Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Recombinant Cell Culture Supplements Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Recombinant Cell Culture Supplements Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Recombinant Cell Culture Supplements Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Recombinant Cell Culture Supplements Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abcam plc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Corning Incorporated
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 BBI Solutions OEM Limited
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 FUJIFILM Irvine Scientific, Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Gemini Bioproducts, LLC
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 HiMedia Laboratories, LLC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Kingfisher Biotech, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Lonza Group AG
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Merck KGaA
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Novus Biologicals, LLC
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Thermo Fisher Scientific Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 InVitria
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Recombinant Cell Culture Supplements Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 526.98 billion in 2023, driven by the rising demand for cell-based therapies.
The market is anticipated to grow at a CAGR of 7.7% during the forecast period of 2024-2032 and reach a market value of USD 1,027.38 billion by 2032.
The increasing demand for animal-free and defined cell culture systems, along with the advancement in production of biopharmaceuticals, are among the major drivers for the market growth.
The product types in the market includes recombinant albumin (ralbumin), recombinant insulin (rinsulin), recombinant epidermal growth factor (regf), recombinant interleukin growth factor (rilgf), recombinant transferrin (rtransferrin), recombinant trypsin (rtrypsin), recombinant insulin-like growth factor (rigf), recombinant stem cell factor (rscf), recombinant aprotinin (raprotinin), and recombinant lysozyme (rlysozyme), among others.
They find wide application in regenerative medicine and bio-production.
The market segment for the expression system includes, mammalian expression system, E. coli expression system, and yeast expression system, among others.
The end user in the market includes academic and research institutions, biotechnology and pharmaceutical companies, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Key players involved in the market are Abcam plc, BBI Solutions OEM Limited Corning Incorporated, FUJIFILM Irvine Scientific, Inc., Gemini Bioproducts, LLC, HiMedia Laboratories, LLC, Kingfisher Biotech, Inc., Lonza Group AG, Merck KGaA, Novus Biologicals, LLC, Thermo Fisher Scientific Inc., and InVitria.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER